| PERIOD ENDING | 1-Oct-09 | 2-Jul-09 | 2-Apr-09 | 31-Dec-08 | | Total Revenue | 1,053,800 | 1,059,600 | 887,400 | 646,100 | | Cost of Revenue | 878,300 | 1,021,600 | 737,300 | 567,100 | | | Gross Profit | 175,500 | 38,000 | 150,100 | 79,000 | | | Operating Expenses | | Research Development | 14,000 | 13,700 | 13,900 | 15,300 | | Selling General and Administrative | 30,500 | 34,700 | 38,400 | 35,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 131,000 | (10,400) | 97,800 | 28,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,100 | 6,200 | 4,100 | 1,400 | | Earnings Before Interest And Taxes | 132,100 | (4,200) | 101,900 | 29,600 | | Interest Expense | 10,200 | 9,800 | 9,100 | 9,700 | | Income Before Tax | 121,900 | (14,000) | 92,800 | 19,900 | | Income Tax Expense | 34,400 | (5,800) | 30,200 | 100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 87,300 | (8,300) | 62,700 | 19,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 87,300 | (8,300) | 62,700 | 19,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $87,300 | ($8,300) | $62,700 | $19,800 |
|
0.51% Nasdaq 
Income Statement
